📰 Current Reports News
Page 27 - Current Reports News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Current Reports. Real-time updates on events, politics, business and more.
April 9, 2024
Global strengthens operations in the Northeast and continues to expand its terminal network ...
April 9, 2024
Expands Traffic and Telecommunication Structures Offerings Provides Entry into Complementary Concrete and Steel Pole Lighting Market Transaction Accelerates Engineered Structures Growth...
April 9, 2024
DALLAS, April 9, 2024 /PRNewswire/ -- Sunoco LP (NYSE: SUN) ("Sunoco" or "SUN") and NuStar Energy L.P. (NYSE: NS) ("NuStar" or "NS") today announced the expiration of the waiting period
April 9, 2024
/PRNewswire/ -- On April 4, 2024, Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") received a letter (the "Letter") from The NASDAQ Stock...
April 8, 2024
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicin...
April 8, 2024
SANTA ANA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE:DCO) ("Ducommun" or the "Company"), a global supplier of innovative electronic systems and structural solutions for the aerospace and
April 8, 2024
Bristol Myers Squibb Releases 2023 ESG Report Demonstrating Progress ...
April 8, 2024
SANTA ANA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”), a global supplier of innovative electronic systems and structural solutions for the aerospace and defense industry, today confirmed that the Company’s Board of Directors has received an unsolicited non-binding indication of interest from Albion River LLC, a private direct investment firm, to acquire all outstanding shares of Ducommun for $60.00...
April 8, 2024
Late-breaking data to be featured in an oral presentation at the American Association for Cancer Research annual meeting on Monday, April 8 and highlighted as part of the official meeting press...
April 8, 2024
Novel Immunotherapy Approach Targets Soluble Tumor Necrosis Factor to Overcome Resistance and Enhance Therapeutic Outcome in High-Risk Breast Cancer Boca Raton, Florida, April 08,...